ClassID:

94187

C07D211/92 - CPC Classification

Classification description:

Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom

Sub-classes:
Recent Application in this class:
#1
20260001890
2026-01-01

Prodrugs of Fumarates and Their Use in Treating Various Diseases

#2
20250081844
2025-03-06

Charge Generation Layer Comprising a Compound of Formula (I), Organic Electronic Device and Display Device Comprising the Charge Generation Layer as Well as Compounds of Formula (I)

#3
20240300969
2024-09-12

Prodrugs of Fumarates and Their Use in Treating Various Diseases

#4
20220356190
2022-11-10

Prodrugs of fumarates and their use in treating various diseases

#5
20220175746
2022-06-09

Indane-amines as PD-L1 antagonists

#6
20210122758
2021-04-29

Prodrugs of fumarates and their use in treating various diseases

#7
20200375962
2020-12-03

Indane-amines as PD-L1 antagonists

#8
20190382413
2019-12-19

PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DISEASES

#9
20190359571
2019-11-28

Method for synthesizing sodium 2,2,6,6-tetramethylpiperidides

#10
20190282555
2019-09-19

Indane-amines as PD-L1 antagonists

#11
20180185422
2018-07-05

Gut barrier dysfunction treatment and prevention

#12
20180030063
2018-02-01

Prodrugs of fumarates and their use in treating various diseases

#13
20180002285
2018-01-04

STERICALLY HINDERED ALKYL AND OXYALKYL AMINE LIGHT STABILIZERS

#14
20160152649
2016-06-02

Metal amides of cyclic amines

#15
20160137660
2016-05-19

PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DISEASES

#16
20150258151
2015-09-17

Gut barrier dysfunction treatment and prevention

#17
20150025245
2015-01-22

Process for preparing chloroamines

#18
20130045169
2013-02-21

Compounds having muscarinic receptor antagonist and beta2 Adrenergic receptor agonist activity

#19
20120042398
2012-02-16

COMPOSITIONS FOR LABELING AND IDENTIFYING AUTOPHAGOSOMES AND METHODS FOR MAKING AND USING THEM

#20
20110112076
2011-05-12

SELECTIVE HYDROXAMIC ACID BASED MMP-12 AND MMP-13 INHIBITORS

#21
20100179324
2010-07-15

ANTI-TUMOR AGENT COMPRISING SULPHOSTIN OR SULPHOSTIN-RELATED COMPOUND AS THE ACTIVE INGREDIENT

#22
20100160632
2010-06-24

Bisamide-zinc bases